clinical_trial 2,910 words KG: rock-inhibitor-fasudil-psp-cbs-nct04734379
Contents

rock-inhibitor-fasudil-psp-cbs-nct04734379

Knowledge Graph

Related Hypotheses (15)

TREM2-Dependent Microglial Senescence Transition
Score: 0.69
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61
Heterogeneous astrocyte activation states differentially imp
Score: 0.52
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52

Related Analyses (9)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Do tau strains or regional cellular environments primarily d
neurodegeneration · failed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived

Related Experiments (16)

4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40

Knowledge Graph (2 edges)

rock-inhibitor-fasudil-psp-cbs-nct04734379 references GFAP
rock-inhibitor-fasudil-psp-cbs-nct04734379 references TREM2